ClinicalTrials.Veeva

Menu

Effectiveness and Implementation of mPATH-CRC

Wake Forest University (WFU) logo

Wake Forest University (WFU)

Status

Completed

Conditions

Rectum Cancer
Colon Cancer
Cancer
Colorectal Cancer

Treatments

Other: mPATH-Checkin
Other: "low touch" Implementation Strategy
Other: mPATH-CRC
Other: "high touch" Implementation strategy

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT03843957
R01CA218416 (U.S. NIH Grant/Contract)
IRB00048919

Details and patient eligibility

About

Study Investigators are conducting this study to learn how to best implement a new iPad program in clinical practice.

Full description

The study team has developed mPATH-CRC (mobile PAtient Technology for Health-Colorectal Cancer), a patient-friendly iPad program used by individuals immediately before a routine primary care visit. mPATH-CheckIn is a module that is used in conjunction with mPATH-CRC that consists of questions asked of all adult patients at check-in. mPATH-CRC is a module specific for patients due for CRC screening.

To fully realize mPATH-CRC's potential to decrease CRC mortality, the program now must be implemented in primary care practices in a way that encourages routine and sustained use. However, while hundreds of mobile health (mHealth) tools have been developed in recent years, the optimal strategies for implementing and maintaining mHealth interventions in clinical practice are unknown. This study will compare the results of a "high touch" strategy to a "low touch" strategy using a Type III hybrid design and incorporating mixed methods to evaluate implementation, maintenance, and effectiveness of mPATH-CRC in a diverse sample of community-based practices.

The study will be conducted in three phases: 1) in a cluster-randomized controlled trial of 22 primary care clinics, the study team will compare the implementation outcomes of a "high touch" evidence-based mHealth implementation strategy with a "low touch" implementation strategy; 2) in a nested pragmatic study, the study team will estimate the effect of mPATH-CRC on completion of CRC screening within 16 weeks of a clinic visit; and 3) by surveying and interviewing clinic staff and providers after implementation is complete, the study team will determine the factors that facilitate or impede the maintenance of mHealth interventions.

Enrollment

77,145 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

This study will include three distinct populations of participants: 1) healthcare providers and staff at primary care practices, 2) patients aged 18 and older seen in the participating study sites, and 3) patients aged 50-74 seen in the participating study sites who are eligible for CRC screening

Patient Inclusion Criteria:

Due for routine CRC screening, defined as:

  • No colonoscopy within the prior 10 years
  • No flexible sigmoidoscopy within the prior 5 years
  • No CT colonography within the prior 5 years
  • No fecal DNA testing within the prior 3 years
  • No fecal blood testing (guaiac-based test with home kit or fecal immunochemical test) within the prior 12 months

Patient Exclusion Criteria:

  • Personal history of CRC
  • First degree relative with CRC
  • Personal history of colorectal polyps

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

77,145 participants in 8 patient groups

Clinic Patients Eligible for CRC Screening on "high touch" Strategy (Post-Implementation)
Experimental group
Description:
English or Spanish-speaking patients aged 50-74 who are eligible for CRC screening who are seen in the study clinics randomized to mPATH utilizing the "high touch" implementation strategy in the 12 months after implementation.
Treatment:
Other: mPATH-CRC
Other: "high touch" Implementation strategy
Other: mPATH-Checkin
Clinic Patients Eligible for CRC Screening on "low touch" Strategy (Post-Implementation)
Experimental group
Description:
English or Spanish-speaking patients aged 50-74 who are eligible for CRC screening who are seen in the study clinics randomized to mPATH utilizing the "low touch" implementation strategy in the 12 months after implementation.
Treatment:
Other: mPATH-CRC
Other: "low touch" Implementation Strategy
Other: mPATH-Checkin
Clinic personnel on "high touch" Strategy (Post-Implementation)
Experimental group
Description:
Clinic personnel (e.g., administrators, nurses, providers) who are involved with the implementation of mPATH-CRC, in the study clinics randomized to mPATH utilizing the "high touch" implementation strategy in the 12 months after implementation.
Treatment:
Other: mPATH-CRC
Other: "high touch" Implementation strategy
Other: mPATH-Checkin
Clinic personnel on "low touch" Strategy (Post-Implementation)
Experimental group
Description:
Clinic personnel (e.g., administrators, nurses, providers) who are involved with the implementation of mPATH-CRC, in the study clinics randomized to mPATH utilizing the "low touch" implementation strategy in the 12 months after implementation.
Treatment:
Other: mPATH-CRC
Other: "low touch" Implementation Strategy
Other: mPATH-Checkin
All Adult Clinic Patients on "high touch" Strategy (Post-Implementation)
Experimental group
Description:
English or Spanish-speaking patients aged 18 or older who are seen in the study clinics randomized to mPATH utilizing the "high touch" implementation strategy in the 12 months after implementation.
Treatment:
Other: "high touch" Implementation strategy
Other: mPATH-Checkin
All Adult Clinic Patients on "low touch" Strategy (Post-Implementation)
Experimental group
Description:
English or Spanish-speaking patients aged 18 or older who are seen in the study clinics randomized to mPATH utilizing the "low touch" implementation strategy in the 12 months after implementation.
Treatment:
Other: "low touch" Implementation Strategy
Other: mPATH-Checkin
Clinic Patients Eligible for CRC Screening on "high touch" Strategy (Pre-Implementation)
Other group
Description:
English or Spanish-speaking patients aged 50-74 who are eligible for CRC screening who are seen in the study clinics randomized to mPATH utilizing the "high touch" implementation strategy but in 8 months before implementation.
Treatment:
Other: "high touch" Implementation strategy
Clinic Patients Eligible for CRC Screening on "low touch" Strategy (Pre-Implementation)
Other group
Description:
English or Spanish-speaking patients aged 50-74 who are eligible for CRC screening who are seen in the study clinics randomized to mPATH utilizing the "low touch" implementation strategy but in 8 months before implementation.
Treatment:
Other: "low touch" Implementation Strategy

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems